Augmedix Stock Fundamentals
AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Augmedix fundamentals help investors to digest information that contributes to Augmedix's financial success or failures. It also enables traders to predict the movement of Augmedix Stock. The fundamental analysis module provides a way to measure Augmedix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Augmedix stock.
Augmedix |
Augmedix Company Current Valuation Analysis
Augmedix's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Augmedix Current Valuation | 113.21 M |
Most of Augmedix's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Augmedix has a Current Valuation of 113.21 M. This is 99.21% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.32% higher than that of the company.
Augmedix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Augmedix's current stock value. Our valuation model uses many indicators to compare Augmedix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Augmedix competition to find correlations between indicators driving Augmedix's intrinsic value. More Info.Augmedix is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Augmedix's earnings, one of the primary drivers of an investment's value.Augmedix Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Augmedix's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics of similar companies.Augmedix is currently under evaluation in current valuation category among its peers.
Augmedix Fundamentals
Return On Equity | -3.3 | |||
Return On Asset | -0.31 | |||
Profit Margin | (0.46) % | |||
Operating Margin | (0.64) % | |||
Current Valuation | 113.21 M | |||
Shares Outstanding | 49.43 M | |||
Shares Owned By Insiders | 1.50 % | |||
Shares Owned By Institutions | 84.78 % | |||
Number Of Shares Shorted | 1.07 M | |||
Price To Book | 11.09 X | |||
Price To Sales | 2.25 X | |||
Revenue | 44.85 M | |||
Gross Profit | 13.95 M | |||
EBITDA | (17.68 M) | |||
Net Income | (19.17 M) | |||
Cash And Equivalents | 29.99 M | |||
Cash Per Share | 0.80 X | |||
Total Debt | 25.85 M | |||
Debt To Equity | 1.54 % | |||
Current Ratio | 2.89 X | |||
Book Value Per Share | 0.21 X | |||
Cash Flow From Operations | (15.44 M) | |||
Short Ratio | 5.73 X | |||
Earnings Per Share | (0.47) X | |||
Target Price | 2.92 | |||
Number Of Employees | 1.43 K | |||
Beta | -0.19 | |||
Market Capitalization | 116.16 M | |||
Total Asset | 66.71 M | |||
Retained Earnings | (144.96 M) | |||
Working Capital | 33.2 M | |||
Net Asset | 66.71 M |
About Augmedix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Augmedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Augmedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Augmedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |